QCM
CLPT icon

Quantinno Capital Management’s ClearPoint Neuro CLPT Stock Holding History

Quantinno Capital Management’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$473K Buy
51,947
+39,195
+307% +$495K ﹤0.01% 2750
2025
Q4 		$174K Buy
+12,752
New +$236K ﹤0.01% 3077

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Quantinno Capital Management's CLPT Position: Q1 2026 in Review

Quantinno Capital Management increased its ClearPoint Neuro (CLPT) stake by 307% in Q1 2026, buying an estimated $495K and bringing the position to 51,947 shares worth $473K. The position accounts for ﹤0.01% of the portfolio, ranked #2750.

Quantinno Capital Management first reported a position in CLPT in Q4 2025 and has held it in 2 quarters since. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • Quantinno Capital Management held 51,947 shares of ClearPoint Neuro worth $473K as of Q1 2026.
  • Quantinno Capital Management bought 39,195 ClearPoint Neuro shares in Q1 2026, an estimated $495K.
  • ClearPoint Neuro made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #2750 holding.
  • Quantinno Capital Management first reported a position in ClearPoint Neuro in Q4 2025 and has held it in 2 quarters since.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.